🇺🇸 FDA

Drug profile · INN

urokinase

KINLYTIC

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

urokinase (KINLYTIC) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN urokinase
Brand KINLYTIC
Route INJECTION
Formulation INJECTABLE

Related patents

Search patents →

  1. US 12331334

    Modified urokinase-type plasminogen activator polypeptides and methods of use

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11613744

    Modified urokinase-type plasminogen activator polypeptides and methods of use

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10239954

    Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9695249

    Antibodies specific for urokinase-type plasminogen activator and methods of use thereof

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9255155

    Antibodies specific for urokinase-type plasminogen activator and methods of treating cancer

    Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9029509

    Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8546322

    Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7332469

    Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is urokinase?

urokinase (KINLYTIC) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for urokinase?

KINLYTIC is a marketed brand name for urokinase. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of urokinase?

urokinase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.